CAR T-Cell therapy revolutionised landscape of cancer treatment: Doctors

CAR T-cell therapy, a groundbreaking immunotherapy, achieved durable remission for Hamza Khan, who battled relapsed follicular lymphoma after failed conventional treatments. Initiated at Narayana Health City in September 2022, this therapy modifies a patient’s immune cells to target cancer effectively. Dr. Sharat Damodar from Narayana Health City highlighted its transformative impact in cancer treatment. Dr. Vipul Sheth of RGCIRC underscored its potential as a “living drug” for refractory cancers resistant to standard therapies like chemotherapy and transplants.